Cybercriminals’ tactics have evolved to target sensitive data and disrupt research and development in the pharmaceutical ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Following are six reasons why pharmaceutical and life sciences companies must prioritize this technology ... from regional distribution centers and third-party carriers to local couriers. This creates ...

To overcome these challenges, both pharmaceutical and biotechnology companies often leverage the experience of strategic partners like contract development and manufacturing organizations (CDMOs ...

We are not responsible for the content or availability of linked sites. ABOUT THIRD PARTY LINKS ON OUR SITE PharmiWeb.com offers links to other third party websites that may be of interest to our ...

Jeddah – United Pharmacies Group has announced the signing of its first strategic agreement for the manufacturing of private-label pharmaceutical and therapeutic products in partnership with Avalon ...

pharma companies too started foraying into the segment thereby offering third-party services in drug manufacturing. Now based on an analysis by EY-Parthenon, there are three major CDMO archetypes ...